Search Results

Featured Stories

Toggle

Showing 2 of 2 results

FDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinson’s Disease

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for AZILECT ® (rasagiline tablets) from monotherapy and adjun...